Biblio
2022
Liu Y, Yan F, Jiang VChangying, Li Y, Che Y, McIntosh J, Jordan A, Hou I, Nie L, Jin J, et al. Pirtobrutinib and venetoclax combination overcomes resistance to targeted and CAR Tcell therapy in aggressive mantle cell lymphoma. Haematologica. 2022.